Allurion Technologies (ALUR) Scheduled to Post Quarterly Earnings on Wednesday

Allurion Technologies (NYSE:ALUR) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. Allurion Technologies has set its FY 2024 guidance at EPS.Parties that are interested in participating in the company’s conference call can do so using this link.

Allurion Technologies (NYSE:ALUR) last posted its earnings results on Tuesday, August 13th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $11.77 million for the quarter. On average, analysts expect Allurion Technologies to post $0 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Allurion Technologies Stock Up 1.9 %

Shares of Allurion Technologies stock opened at $0.71 on Wednesday. The firm has a market cap of $45.40 million, a PE ratio of -0.80 and a beta of -0.37. Allurion Technologies has a twelve month low of $0.55 and a twelve month high of $4.64. The business has a 50-day moving average price of $0.67 and a 200 day moving average price of $1.10.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ALUR. TD Cowen began coverage on Allurion Technologies in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $2.00 price objective for the company. Roth Capital upgraded shares of Allurion Technologies to a “strong-buy” rating in a research report on Friday, September 6th. Chardan Capital dropped their target price on shares of Allurion Technologies from $5.00 to $2.50 and set a “buy” rating on the stock in a research report on Thursday, August 22nd. Finally, Roth Mkm started coverage on shares of Allurion Technologies in a research report on Friday, September 6th. They set a “buy” rating and a $2.00 price target for the company. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $2.88.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.